Cancer Immunology, Immunotherapy

Clinical impact of HLA class I expression in rectal cancer

• Open Access
• Original Article

Frank M. Speetjens, Elza C. de Bruin, Hans Morreau, Eliane C. M. Zeestraten, Hein Putter, J. Han van Krieken, Maaike M. van Buren, Monique van Velzen, N. Geeske Dekker-Ensink, Cornelis J. H. van de Velde, Peter J. K. Kuppen

An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2

• Original Article

Tsukasa Nabekura, Toshiro Nagasawa, Hiromitsu Nakauchi, Masafumi Onodera

Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma

• Original Article

Fiona C. Thistlethwaite, Eyad Elkord, Richard W. Griffiths, Deborah J. Burt, Alaaeldin M. Shablak, John D. M. Campbell, David E. Gilham, Eric B. Austin, Peter L. Stern, Robert E. Hawkins

Migration deficit in monocyte-macrophages in human ovarian cancer

• Original Article

Ralph S. Freedman, Qing Ma, Ena Wang, Stacie T. Gallardo, Ilyssa O. Gordon, Jeong Won Shin, Ping Jin, David Stroncek, Francesco M. Marincola

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

• Original Article

A. Nazmul H. Khan, Christopher J. Gregorie, Thomas B. Tomasi

Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model

• Original Article

Melissa A. Barber, Tong Zhang, Bethany A. Gagne, Jo A. Van Ginderachter, Patrick De Baetselier, Charles L. Sentman

Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction

• Original Article

Hovav Nechushtan, Dien Pham, Yu Zhang, Daniel Morgensztern, Kyung H. Yi, Seung-Uon Shin, Howard J. Federoff, William J. Bowers, Khaled A. Tolba, Joseph D. Rosenblatt

Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients

• Original Article

Hui Wang, Chuanping Cao, Beilei Li, Shaoliang Chen, Jun Yin, Jing Shi, Dan Ye, Qun Tao, Peisheng Hu, Alan Epstein, Dianwen Ju

Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy

• Original Article

Selma Ugurel, David Schrama, Gunhild Keller, Dirk Schadendorf, Eva-Bettina Bröcker, Roland Houben, Marc Zapatka, Wolfram Fink, Howard L. Kaufman, Jürgen C. Becker

MYCN as a target for cancer immunotherapy

• Original Article

Nourredine Himoudi, Mengyong Yan, Antigoni Papanastasiou, John Anderson

Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors

• Original Article

Paula Chiarella, Marisa Vulcano, Juan Bruzzo, Mónica Vermeulen, Silvia Vanzulli, Andrea Maglioco, Gabriela Camerano, Víctor Palacios, Gabriela Fernández, Romina Fernández Brando, Martín A. Isturiz, Graciela I. Dran, Oscar D. Bustuoabad, Raúl A. Ruggiero

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

• Original Article

Rosa Méndez, Teresa Rodríguez, Ana Del Campo, Eva Monge, Isabel Maleno, Natalia Aptsiauri, Pilar Jiménez, Susana Pedrinaci, Graham Pawelec, Francisco Ruiz-Cabello, Federico Garrido

Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma

• Original Article

Anna De Geer, Lena-Maria Carlson, Per Kogner, Jelena Levitskaya

A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes

• Original Article

Pierre Larrieu, Virginie Renaud, Yann Godet, Francine Jotereau, Jean-François Fonteneau

Acknowledgement

• Open Access
• Acknowledgement to Reviewers